A phase 1b/2 study of ribociclib plus trastuzumab for the treatment of advanced, treatment-refractory HER2-positive breast cancer

S. Goel,L. Spring,R. Rees, C. Andrews, R. K. Tahara,E. L. Mayer,A. Bardia,E. P. Winer, S. M. Tolaney

CANCER RESEARCH(2019)

引用 2|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要